Rift vs. ShedRx: prices, fine print, and the honest verdict

Tirzepatide pricing

Rift offers tirzepatide without a published price we could capture. ShedRx: $289 a month all-in at the 10 mg maintenance basis, dose-scaled from a $199 entry, no membership fee.

Semaglutide pricing

Only ShedRx publishes a semaglutide price here: Semaglutide runs $249 a month all-in at the standing rate ($175 on intro/plan terms). Rift offers semaglutide without a published price.

Transparency

Rift: No price published (verified 2026-08-05); dispensing pharmacy not publicly named. ShedRx: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Rift: unknown; not published. ShedRx: none month-to-month; 72-hour notice before the next billing cycle.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: ShedRx scales $199 → ~$289 by 10 mg (titration lands between $796 and $1,156). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

Only ShedRx fields a verified semaglutide price here — $249/month all-in (#13 of 19) — while Rift publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Rift publishes no figure to normalize; ShedRx's ranked figure is $289, with no membership to add. 2 · Maintenance basis. ShedRx scales from $199 to $289, and the 10 mg figure is the one ranked. 3 · Terms separated. ShedRx: standing $289, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Rift: no price published, read 2026-08-05; ShedRx: source-verified, read 2026-08-05. 5 · Pharmacy weighed. Rift names no pharmacy; ShedRx names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Rift: no membership — the medication figure is the billed figure; not published; commitment: unknown. ShedRx: no membership — the medication figure is the billed figure; 72-hour notice before the next billing cycle; commitment: none month-to-month. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Rift carries no price published pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. ShedRx carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Rift-to-ShedRx move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Rift: shipping unknown; consultation unknown. ShedRx: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Rift if its published terms happen to fit your state, format, or timing. Pick ShedRx if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Rift, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are Found at $289 (flat, no membership); OrderlyMeds at $299 (flat, no membership); SkinnyRx at $299 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $1,920/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.